Display Settings:

Format

Send to:

Choose Destination
    Dev Biol. 2010 Jun 15;342(2):169-79. Epub 2010 Mar 30.

    Genetic evidence that SOST inhibits WNT signaling in the limb.

    Source

    Biology and Biotechnology Division, Lawrence Livermore National Laboratory, Livermore, CA 94550, USA.

    Abstract

    SOST is a negative regulator of bone formation, and mutations in human SOST are responsible for sclerosteosis. In addition to high bone mass, sclerosteosis patients occasionally display hand defects, suggesting that SOST may function embryonically. Here we report that overexpression of SOST leads to loss of posterior structures of the zeugopod and autopod by perturbing anterior-posterior and proximal-distal signaling centers in the developing limb. Mutant mice that overexpress SOST in combination with Grem1 and Lrp6 mutations display more severe limb defects than single mutants alone, while Sost(-/-) significantly rescues the Lrp6(-/-) skeletal phenotype, signifying that SOST gain-of-function impairs limb patterning by inhibiting the WNT signaling through LRP5/6.

    Copyright 2010 Elsevier Inc. All rights reserved.

    PMID:
    20359476
    [PubMed - indexed for MEDLINE]
    PMCID:
    PMC2896299
    Free PMC Article

    Images from this publication.See all images (5) Free text

    Figure 1
    Figure 3
    Figure 5
    Figure 2
    Figure 4

      Supplemental Content

      Icon for Elsevier Science Icon for PubMed Central

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk